Table 3.
Baseline characteristics of the 209 APHIV included according to HIV-serostatus disclosure at 24-month, in the COHADO cohort, Abidjan (Côte d'Ivoire), Lomé (Togo), IeDEA-pWADA, 2015–2017.
|
Total N = 209 (%) |
HIV-status disclosed before inclusion in COHADO N = 87 (%) |
HIV-status disclosed during follow-up in COHADO N = 68 (%) |
HIV-status still not disclosed at the last follow-up N = 54 (%) |
P-Valuea | |
|---|---|---|---|---|---|
| Sex, n (%) | 0.64 | ||||
| Males | 95 (45.4) | 37 (42.5) | 34 (50.0) | 24 (44.4) | |
| Females | 114 (54.6) | 50 (57.5) | 34 (50.0) | 30 (55.6) | |
| Site, n (%) | <0.01 | ||||
| Abidjan (Côte-d'Ivoire) | 108 (51.7) | 62 (71.3) | 15 (22.1) | 31 (57.4) | |
| Lomé (Togo) | 101 (48.3) | 25 (28.7) | 53 (77.9) | 23 (42.6) | |
| Age at baseline in years, median [IQR] | 13[11–15] | 15[14–17] | 12[11–14] | 11[10–12] | <0.01c |
| Orphanhood, n (%) | 0.36 | ||||
| No | 91 (43.5) | 31 (35.6) | 31 (47.1) | 28 (51.6) | |
| One parent | 91 (43.5) | 43 (49.4) | 27 (39.7) | 21 (38.9) | |
| Two parents | 27 (13.0) | 13 (14.9) | 9 (13.2) | 5 (9.3) | |
| Education level | <0.01b | ||||
| Primary school | 80 (38.3) | 14 (16.1) | 31 (45.6) | 35 (64.8) | |
| Middle schools | 103 (49.3) | 49 (56.3) | 35 (51.5) | 19 (35.2) | |
| High schools | 26 (12.4) | 24 (27.6) | 2 (2.9) | 0 (0.0) | |
| Running water access | <0.01 | ||||
| Yes | 131 (62.7) | 67 (77.0) | 32 (47.1) | 32 (59.3) | |
| No | 78 (37.3) | 20 (22.9) | 36 (52.9) | 22 (40.7) | |
| Electricity access, n (%) | 0.76 | ||||
| No | 6 (2.9) | 3 (3.4) | 1 (1.5) | 2 (3.7) | |
| Yes | 203 (97.1) | 84 (96.6) | 67 (98.5) | 52 (96.3) | |
| Residential environment | 0.53 | ||||
| Urban | 187 (89.5) | 77 (88.5) | 63 (92.6) | 47 (87.1) | |
| Rural | 22 (10.5) | 10 (11.5) | 5 (7.4) | 7 (12.9) | |
| Living with | 0.94 | ||||
| Both parents | 50 (23.9) | 19 (21.8) | 18 (26.5) | 13 (24.1) | |
| Only one parent | 93 (44.5) | 38 (43.7) | 30 (44.1) | 25 (46.3) | |
| Other family member | 66 (31.6) | 30 (34.5) | 20 (29.4) | 16 (29.6) | |
| WHO clinical stage, n (%) | 0.41b | ||||
| 1, 2, 3 | 173 (82.8) | 73 (83.9) | 53 (77.9) | 47 (87.1) | |
| 4 (AIDS) | 36 (17.2) | 14 (16.1) | 15 (22.1) | 7 (12.9) | |
| Virological suppression (n = 62), | |||||
| (Viral load <50 cp/mL) | 0.68b | ||||
| Yes | 2 (3.2) | 1 (2.9) | 0 (0.0) | 1 (6.3) | |
| No | 60 (97.8) | 34 (97.1) | 11 (100.0) | 15 (93.7) | |
| CD4 cell count/mm3, median [IQR] | |||||
| 521[281–758] | 492[225–734] | 507[262–850] | 548[416–843] | 0.08c |
a
Chi2 test;
b
Fisher's exact test;
c
Kruskal-Wallis test.